Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 3
2015 1
2016 1
2017 3
2018 1
2019 2
2020 3
2021 2
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry.
Meegdes M, Geurts SME, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Peters NAJB, Tol J, Heijns JB, van de Wouw AJ, de Fallois AJO, van Kats MACE, Tjan-Heijnen VCG. Meegdes M, et al. Among authors: dercksen mw. Lancet Reg Health Eur. 2023 Jan 6;26:100573. doi: 10.1016/j.lanepe.2022.100573. eCollection 2023 Mar. Lancet Reg Health Eur. 2023. PMID: 36895447 Free PMC article.
[Infection or metastases? The amoebic abscess].
Heil TC, Dercksen MW, Blank SN. Heil TC, et al. Among authors: dercksen mw. Ned Tijdschr Geneeskd. 2018 Jul 20;162:D2580. Ned Tijdschr Geneeskd. 2018. PMID: 30182627 Dutch.
Paraganglion, a pitfall in diagnosis after regular cholecystectomy.
Corten BJGA, Leclercq WKG, Dercksen MW, van den Broek WT, van Zwam PH, Dejong CH, Slooter GD. Corten BJGA, et al. Among authors: dercksen mw. Int J Surg Case Rep. 2019;65:205-208. doi: 10.1016/j.ijscr.2019.10.042. Epub 2019 Oct 28. Int J Surg Case Rep. 2019. PMID: 31731083 Free PMC article.
Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin.
Hermans BCM, de Vos-Geelen J, Derks JL, Latten L, Liem IH, van der Zwan JM, Speel EM, Dercksen MW, Dingemans AC. Hermans BCM, et al. Among authors: dercksen mw. Neuroendocrinology. 2021;111(11):1111-1120. doi: 10.1159/000513249. Epub 2020 Nov 23. Neuroendocrinology. 2021. PMID: 33227805 Free article.
The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry.
Meegdes M, Geurts SME, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Teeuwen NJA, de Boer M, Tjan-Heijnen VCG. Meegdes M, et al. Int J Cancer. 2022 Jan 1;150(1):124-131. doi: 10.1002/ijc.33785. Epub 2021 Sep 14. Int J Cancer. 2022. PMID: 34460112 Free PMC article.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, Kooreman LFS, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Tol J, Heijns JB, van de Wouw AJ, Peters NAJB, Hochstenbach-Waelen A, Smidt ML, Geurts SME, Tjan-Heijnen VCG. Meegdes M, et al. Among authors: dercksen mw. Breast Cancer Res Treat. 2022 Apr;192(2):331-342. doi: 10.1007/s10549-021-06472-5. Epub 2022 Jan 13. Breast Cancer Res Treat. 2022. PMID: 35025003 Free PMC article.
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Vriens IJH, Ter Welle-Butalid EM, de Boer M, de Die-Smulders CEM, Derhaag JG, Geurts SME, van Hellemond IEG, Luiten EJT, Dercksen MW, Lemaire BMD, van Haaren ERM, Vriens BEPJ, van de Wouw AJ, van Riel AMGH, Janssen-Engelen SLE, van de Poel MHW, Schepers-van der Sterren EEM, van Golde RJT, Tjan-Heijnen VCG. Vriens IJH, et al. Among authors: dercksen mw. Breast Cancer Res Treat. 2020 May;181(1):77-86. doi: 10.1007/s10549-020-05598-2. Epub 2020 Mar 31. Breast Cancer Res Treat. 2020. PMID: 32236826 Free PMC article.
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
de Groot S, Pijl H, Charehbili A, van de Ven S, Smit VTHBM, Meershoek-Klein Kranenbarg E, Heijns JB, van Warmerdam LJC, Kessels LW, Dercksen MW, Pepels MJAE, van Laarhoven HWM, Vriens BEPJ, Putter H, Fiocco M, Liefers GJ, van der Hoeven JJM, Nortier JWR, Kroep JR; Dutch Breast Cancer Research Group. de Groot S, et al. Among authors: dercksen mw. Breast Cancer Res. 2019 Aug 28;21(1):97. doi: 10.1186/s13058-019-1180-6. Breast Cancer Res. 2019. PMID: 31455425 Free PMC article.
20 results